Evidence map›Paper›PMID 35618675›Full record

ArticleZoonoses and public health2022

Building on health security capacities in Indonesia: Lessons learned from the COVID-19 pandemic responses and challenges.

Dewi Nur Aisyah, Chyntia Aryanti Mayadewi, Meiwita Budiharsana, Dewi Amila Solikha, Pungkas Bahjuri Ali, Gayatri Igusti, Zisis Kozlakidis, Logan Manikam

Abstract read
In one paragraph

Article in Zoonoses and public health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Dewi Nur AisyahDepartment of Epidemiology and Public Health, Institute of Epidemiology and Health Care, University College London, London, UK.
Chyntia Aryanti MayadewiIndonesia One Health University Network, Depok, Indonesia.
Meiwita BudiharsanaFaculty of Public Health, Universitas Indonesia, Depok, Indonesia.
Dewi Amila SolikhaMinistry of National Development Planning (BAPPENAS) of the Republic of Indonesia, Jakarta, Indonesia.
Pungkas Bahjuri AliMinistry of National Development Planning (BAPPENAS) of the Republic of Indonesia, Jakarta, Indonesia.
Gayatri IgustiAceso Global Health Consultants Limited, London, UK.
Zisis KozlakidisInternational Agency for Research on Cancer World Health Organization, Lyon, France.
Logan ManikamDepartment of Epidemiology and Public Health, Institute of Epidemiology and Health Care, University College London, London, UK.

Funding

World Health Organization 001
6 · The paper itself

Abstract

As an active member country of the WHO's International Health Regulation and Global Health Security Agenda, Indonesia, the world's fourth-most populous and largest archipelagic country has recorded the second-highest COVID-19 cases in Asia with over 1.8 million cases in early June 2021. This geographically and socially diverse country has a dynamic national and sub-national government coordination with decentralized authorities that can complicate a pandemic response which often requires nationally harmonized policies, adaptability to sub-national contexts and global interconnectedness. This paper analyses and reviews COVID-19 public data, regulations, guidance documents, statements and other related official documents to present a narrative that summarizes the government's COVID-19 response strategies. It further analyses the challenges and achievements of the country's zoonotic diseases preparedness and responses and lastly provides relevant recommendations. Findings are presented in four sections according to the Global Health Security Agenda capacities, namely epidemiological surveillance (detect capacity); laboratory diagnostic testing (respond capacity); data management and analysis (enable capacity); and the role of sub-national governments. The COVID-19 pandemic has been a catalyst for the rapid transformation of existing surveillance systems, inter-related stakeholder coordination and agile development from the pre-pandemic health security capacities. This paper offers several recommendations on surveillance, laboratory capacity and data management, which might be useful for Indonesia and other countries with similar characteristics beyond the COVID-19 response, such as achieving long-term health security, zoonoses and pandemic prevention, as well as a digital transformation of their governmental capacities.

Indexed as

COVID-19AnimalsGlobal HealthIndonesiaPandemicsCOVID-19health securityIndonesialaboratoriespandemicspolicy

Identifiers

PMID35618675
PMCPMC9348171

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.